Shantou University Medical College

Academic/Hospital

Also known as: Affiliated Cancer Hospital of Shantou University Medical College | Affiliated Cancer Hospital of Shantou University Medical College Medical | Chuangzhen Chen

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Aug 1, 2012

Last known activity

Aug 15, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (16 distinct, 10 trials)

Phase 4 (5 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

tislelizumab

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT07095023CollaboratorN/AAug 15, 2025
NCT07104604Lead sponsorPhase 1Aug 1, 2025
NCT07104604Sponsor investigatorPhase 1Aug 1, 2025
NCT07020468Sponsor investigatorPhase 4May 15, 2025
NCT07020468Lead sponsorPhase 4May 15, 2025
NCT07020468OfficialPhase 4May 15, 2025
NCT06750848Lead sponsorPhase 2Dec 20, 2024
NCT06750848Sponsor investigatorPhase 2Dec 20, 2024
NCT05984342Reponsible party - principal investigatorPhase 1Aug 2, 2023
NCT05984342Lead sponsorPhase 1Aug 2, 2023
NCT05357846CollaboratorPhase 3Nov 1, 2022
NCT04991493Reponsible party - principal investigatorPhase 4Sep 10, 2021
NCT04991493Lead sponsorPhase 4Sep 10, 2021
NCT04991493Overall official - principal investigatorPhase 4Sep 10, 2021
NCT02556762Lead sponsorPhase 3Aug 1, 2015

Details

Last known activity: Aug 15, 2025